Efficacy of the WeCareAdvisor: An Online Tool to Help Caregivers Manage Behavioral and Psychological Symptoms in Persons with Dementia
WeCareAdvisor 的功效:帮助护理人员管理痴呆症患者行为和心理症状的在线工具
基本信息
- 批准号:10247666
- 负责人:
- 金额:$ 75.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-08-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAggressive behaviorAgitationAlgorithmsAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAntipsychotic AgentsBehaviorBehavior monitoringBehavioralBehavioral SymptomsCaregiversCaringCaucasiansCommunicationComplexControl GroupsCustomDementiaDevelopmentDiseaseDisease ProgressionDistressEducationElectronic MailEnvironmentEtiologyEvaluationFDA approvedFamilyFamily CaregiverFamily memberFrequenciesFundingGoalsGrantHealth PersonnelKnowledgeLearningLeftMediator of activation proteinMotivationNursing HomesOnline SystemsOutcomePainPersonsPharmaceutical PreparationsRaceRandomizedReadinessReportingResearchReview LiteratureRiskSamplingSelf EfficacySeriesSeveritiesSocietiesSpousesSymptomsTelephoneTestingUnited States National Academy of SciencesWaiting Listsbasecare systemscostdementia caredesignefficacy testingefficacy trialfamily burdenfamily caregivingfamily supporthealth care service utilizationhigh riskimprovedmortalitynovelpreventprimary endpointpsychological symptomracial diversityrandomized trialresponseside effectskillssymposiumtooltreatment grouptreatment planningusabilityweb-based tool
项目摘要
Behavioral and psychological symptoms (agitation, aggression, among many others; aka BPSD) are hallmarks
of Alzheimer's disease and related dementias (ADRD). BPSD dominate disease presentation, occur across
etiologies and disease trajectories, and have significant negative consequences for persons with dementia,
family members, and society at-large. Although there are no FDA approved medications to treat BPSD,
psychotropic medications (including anti-psychotics) are commonly used with limited efficacy and high risk.
Nonpharmacologic strategies are considered first-line treatments and have proven efficacy, but families have
little knowledge of and access to strategies and are left on their own to manage BPSD. In response, we
developed an easy-to-use, web-based platform, WeCareAdvisor, through a previously funded NINR grant (R01
NR014200) for use by family caregivers. The tool provides caregivers with knowledge about dementia, daily
tips, and a systematic approach for describing, investigating, creating and evaluating strategies using an
approach we developed (DICE) that systematically guides selection of strategies to match symptom
presentation. Our pilot randomized study (N=57; NIA-Stage 1) compared an initial treatment group to a 1-
month waitlist control with caregivers receiving weekly telephone calls and emails encouraging tool use. This
pilot demonstrated proof-of-concept with 100% of caregivers using the tool. After 1 month of use, both the
initial treatment and the waitlist control groups showed significant within group benefits in caregiver (distress,
confidence) and BPSD (frequency and severity) outcomes. Additionally, there was significant improvement in
caregiver distress in the initial treatment group as compared to the waitlist group. Unclear, is whether prompts
were necessary for tool use and/or to derive benefit. In response to PAR-18-027, we propose to test the
efficacy of WeCareAdvisor (NIA - Stage II) and tool utilization in 326 diverse caregivers using a two-group,
randomized design; caregivers will be assigned to immediate treatment or 3-month waitlist control groups. Our
specific aims are to test: 1) Short-term efficacy (1-month) of WeCareAdvisor on caregiver distress, confidence
managing BPSD, or BPSD frequency and severity; 2) Longer-term efficacy (3-months) of WeCareAdvisor on
caregiver distress, confidence managing BPSD, or BPSD frequency and severity. We will also examine
whether the waitlist control group demonstrates similar benefits after using the tool over a 3-month exposure;
and 3) Tool utilization and outcomes using different reminders (telephone + email or email only). We will also
evaluate whether tool utilization is sustained without prompts in months 3-6 for the initial treatment group.
Exploratory aims will examine frequency of use of tool components, impact on psychotropic medication use,
function, and other outcomes; and mediator (theoretically-derived variables), and moderator (race, relationship)
effects. This proposal is novel in assessing efficacy and utilization of a tool that has great potential to impact
dementia care by providing caregivers with on-demand access to BPSD management strategies.
行为和心理症状(激动,侵略,其中许多;又名BPSD)是标志
阿尔茨海默病和相关痴呆症(ADRD)。BPSD主导疾病表现,发生于
病因和疾病轨迹,并对痴呆症患者产生重大负面影响,
家庭成员和整个社会。虽然没有FDA批准的药物来治疗BPSD,
精神科药物(包括抗精神病药物)普遍使用,但疗效有限,而且风险高。
非药物策略被认为是一线治疗,并已证明有效,但家庭
缺乏战略知识和获取战略的途径,只能靠自己管理BPSD。作为回应,我们
通过先前资助的NINR赠款(R 01),开发了一个易于使用的基于网络的平台WeCareAdvisor
NR 014200)供家庭护理人员使用。该工具每天为护理人员提供有关痴呆症的知识
提示,以及使用一个系统的方法来描述,调查,创建和评估战略,
我们开发了一种方法(DICE),系统地指导选择与症状相匹配的策略
演示文稿.我们的初步随机研究(N=57; NIA-Stage 1)比较了初始治疗组和1-
一个月的等待名单控制与照顾者每周收到电话和电子邮件,鼓励工具的使用。这
试点展示了概念验证,100%的护理人员使用该工具。使用1个月后,
初始治疗组和等待名单对照组在照顾者方面显示出显著的组内益处(痛苦,
置信度)和BPSD(频率和严重程度)结果。此外,
与等待名单组相比,初始治疗组的护理人员痛苦。不清楚,是否提示
是工具使用和/或获益所必需的。根据PAR-18-027,我们建议测试
WeCareAdvisor(NIA -第二阶段)的有效性和326名不同护理人员的工具利用率,
随机设计;护理人员将被分配到立即治疗组或3个月等待名单对照组。我们
具体目标是测试:1)WeCareAdvisor对护理人员痛苦,信心的短期疗效(1个月)
管理BPSD或BPSD频率和严重程度; 2)WeCareAdvisor对以下患者的长期疗效(3个月)
护理者苦恼、管理BPSD的信心或BPSD频率和严重性。我们亦会研究
等待名单对照组在使用该工具3个月后是否表现出类似的益处;
以及3)使用不同提醒(电话+电子邮件或仅电子邮件)的工具利用率和结果。我们还将
评估初始治疗组在3-6个月内是否在没有提示的情况下持续使用工具。
探索性目的将检查工具组件的使用频率,对精神药物使用的影响,
功能,和其他结果;和中介(理论衍生变量),和调节(种族,关系)
方面的影响.这一建议在评估一种具有巨大影响潜力的工具的功效和利用方面是新颖的
通过向护理人员提供BPSD管理策略的按需访问,提供痴呆症护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Laura N. Gitlin其他文献
A Biobehavioral Home-Based Intervention and the Well-being of Patients With Dementia and Their Caregivers
生物行为家庭干预和痴呆症患者及其护理人员的福祉
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:0
- 作者:
Laura N. Gitlin;Marie P. Dennis;N. Hodgson;Walter W. Hauck - 通讯作者:
Walter W. Hauck
“The Filter is Kind of Broken”: Family Caregivers' Attributions About Behavioral and Psychological Symptoms of Dementia
- DOI:
10.1016/j.jagp.2017.12.004 - 发表时间:
2018-05-01 - 期刊:
- 影响因子:
- 作者:
Courtney A. Polenick;Laura M. Struble;Barbara Stanislawski;Molly Turnwald;Brianna Broderick;Laura N. Gitlin;Helen C. Kales - 通讯作者:
Helen C. Kales
In Search of Psychological Benefits
寻求心理益处
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:0
- 作者:
Laura N. Gitlin;M. P. Lawton;Lisa A. Windsor;M. Kleban;Laura P. Sands;J. Posner - 通讯作者:
J. Posner
Family dementia caregivers with suicidal ideation improve with mentalizing imagery therapy: Results from a pilot study
有自杀意念的家庭痴呆症护理人员通过心理意象疗法得到改善:一项试点研究的结果
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Saira Madarasmi;Paulina Gutierrez‐Ramirez;Nader Barsoum;Sreya Banerjee;Liliana Ramirez Gomez;Maria Melero‐Dominguez;Laura N. Gitlin;Aderonke Pederson;Richard T. Liu;Felipe A Jain - 通讯作者:
Felipe A Jain
Understanding the implementation process of the Adult Day Services Plus program
- DOI:
10.1186/s12877-025-05757-4 - 发表时间:
2025-02-13 - 期刊:
- 影响因子:3.800
- 作者:
Quinton D. Cotton;Dionne Bailey;Elle Albers;Steph Ingvalson;Emily Bloomquist;Katie Marx;Keith Anderson;Holly Dabelko-Schoeny;Lauren Parker;Laura N. Gitlin;Joseph E. Gaugler - 通讯作者:
Joseph E. Gaugler
Laura N. Gitlin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Laura N. Gitlin', 18)}}的其他基金
Efficacy of the WeCareAdvisor: An Online Tool to Help Caregivers Manage Behavioral and Psychological Symptoms in Persons with Dementia
WeCareAdvisor 的功效:帮助护理人员管理痴呆症患者行为和心理症状的在线工具
- 批准号:
10665635 - 财政年份:2019
- 资助金额:
$ 75.46万 - 项目类别:
Efficacy of the WeCareAdvisor: An Online Tool to Help Caregivers Manage Behavioral and Psychological Symptoms in Persons with Dementia
WeCareAdvisor 的功效:帮助护理人员管理痴呆症患者行为和心理症状的在线工具
- 批准号:
10447723 - 财政年份:2019
- 资助金额:
$ 75.46万 - 项目类别:
Efficacy of the WeCareAdvisor: An Online Tool to Help Caregivers Manage Behavioral and Psychological Symptoms in Persons with Dementia
WeCareAdvisor 的功效:帮助护理人员管理痴呆症患者行为和心理症状的在线工具
- 批准号:
9979719 - 财政年份:2019
- 资助金额:
$ 75.46万 - 项目类别:
The Johns Hopkins Alzheimer's Disease Resource Center for Minority Aging Research - Research Ed Component
约翰·霍普金斯大学阿尔茨海默氏病资源中心少数民族老龄化研究 - 研究版组件
- 批准号:
10451582 - 财政年份:2018
- 资助金额:
$ 75.46万 - 项目类别:
A Training and Fidelity Model to Move and Scale Evidence-based Dementia Care and Caregiver Support Programs into Practice: The Case for COPE in PACE service settings
将循证痴呆症护理和护理人员支持计划付诸实践的培训和保真模型:PACE 服务环境中的 COPE 案例
- 批准号:
10186679 - 财政年份:2018
- 资助金额:
$ 75.46万 - 项目类别:
A Training and Fidelity Model to Move and Scale Evidence-based Dementia Care and Caregiver Support Programs into Practice: The Case for COPE in PACE service settings
将循证痴呆症护理和护理人员支持计划付诸实践的培训和保真模型:PACE 服务环境中的 COPE 案例
- 批准号:
10468726 - 财政年份:2018
- 资助金额:
$ 75.46万 - 项目类别:
A Training and Fidelity Model to Move and Scale Evidence-based Dementia Care and Caregiver Support Programs into Practice: The Case for COPE in PACE service settings
将循证痴呆症护理和护理人员支持计划付诸实践的培训和保真模型:PACE 服务环境中的 COPE 案例
- 批准号:
9789806 - 财政年份:2018
- 资助金额:
$ 75.46万 - 项目类别:
相似海外基金
Relationship between two types of narcissism, anger, aggressive behavior and adaptation
两种自恋、愤怒、攻击行为和适应之间的关系
- 批准号:
23K18995 - 财政年份:2023
- 资助金额:
$ 75.46万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Molecular biomarkers of future aggressive behavior in pituitary tumors
垂体瘤未来攻击行为的分子生物标志物
- 批准号:
10650948 - 财政年份:2023
- 资助金额:
$ 75.46万 - 项目类别:
Neuronal mechanisms of visually-driven aggressive behavior
视觉驱动攻击行为的神经机制
- 批准号:
9978478 - 财政年份:2020
- 资助金额:
$ 75.46万 - 项目类别:
Development of a Nursing Intervention Model to Prevent Aggressive Behavior in Hospitalized Elderly Patients with Dementia
预防住院老年痴呆症患者攻击行为的护理干预模型的建立
- 批准号:
20K23236 - 财政年份:2020
- 资助金额:
$ 75.46万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of a Management Sheet on Aggressive Behavior for Working with Patients in a Psychiatric Ward
为精神科病房的患者制定攻击行为管理表
- 批准号:
18K10309 - 财政年份:2018
- 资助金额:
$ 75.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Social determinants of corticolimbic development and aggressive behavior
皮质边缘发育和攻击行为的社会决定因素
- 批准号:
9765038 - 财政年份:2018
- 资助金额:
$ 75.46万 - 项目类别:
Examination of factors that promote and suppress aggressive behavior on the Internet
检查促进和抑制互联网上攻击行为的因素
- 批准号:
17K04438 - 财政年份:2017
- 资助金额:
$ 75.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identifying patterns and mechanistic pathways from violence exposure trajectories to aggressive behavior and psychological disorders
识别从暴力暴露轨迹到攻击行为和心理障碍的模式和机制路径
- 批准号:
9372567 - 财政年份:2017
- 资助金额:
$ 75.46万 - 项目类别:
EAPSI: The Role of Monoamine Oxidase - A Gene Polymorphism in Aggressive Behavior in Macaques
EAPSI:单胺氧化酶的作用 - 基因多态性在猕猴攻击行为中的作用
- 批准号:
1713932 - 财政年份:2017
- 资助金额:
$ 75.46万 - 项目类别:
Fellowship Award
analysis on genetic abnormality related to aggressive behavior of uterine leiomyosarcoma
子宫平滑肌肉瘤侵袭行为相关基因异常分析
- 批准号:
16K11124 - 财政年份:2016
- 资助金额:
$ 75.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)